Aclarion Sets Strategic Guardrails
Aclarion Inc. has announced a strategic dual-approach to its corporate governance and commercial growth, combining a new defensive shareholder measure with an optimistic roadmap for its AI-driven medical technology. The company board of directors has officially adopted a limited-duration stockholder rights plan. This measure is designed to protect the company and its investors from any…more










